Real-world evidence on the disparities in prescribing of dipeptidylpeptidase-4 inhibitors in UK primary care

AP McGovern; W Hinton; J van Vlymen; N Munro; M Whyte; S de Lusignan

Back

Real-world evidence on the disparities in prescribing of dipeptidylpeptidase-4 inhibitors in UK primary care

Journal article

Peer reviewed

Real-world evidence on the disparities in prescribing of dipeptidylpeptidase-4 inhibitors in UK primary care

AP McGovern, W Hinton, J van Vlymen, N Munro, M Whyte and S de Lusignan

DIABETIC MEDICINE, Vol.33, pp.183-183

01/03/2016

Abstract

Science & Technology

Life Sciences & Biomedicine

Endocrinology & Metabolism

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000372304800497&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

27 Record Views

Details

Title: Real-world evidence on the disparities in prescribing of dipeptidylpeptidase-4 inhibitors in UK primary care
Creators: AP McGovern
W Hinton
J van Vlymen
N Munro
M Whyte
S de Lusignan
Publication Details: DIABETIC MEDICINE, Vol.33, pp.183-183
Publisher: WILEY-BLACKWELL
Date published: 01/03/2016
Date submitted: 17/05/2017
Identifiers: 99515561402346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Real-world evidence on the disparities in prescribing of dipeptidylpeptidase-4 inhibitors in UK primary care

Abstract

Files and links (1)

Metrics

Details

Usage Policy